FDA recall record

Jiangsu Well Biotech Co.,Ltd recall — FDA Z-0001-2023

Distribution of COVID-19 Ag Rapid Test kits in the U.S. without an Emergency Use Authorization, or a Pre-Market Approval or Clearance.

Class Iclassification
Z-0001-2023official record ID
Oct 19, 2022report date

Recall record at a glance

Official recordZ-0001-2023
CategoryMedical Device Recalls
ClassificationClass I
FDA record statusOngoing
Recalling firmJiangsu Well Biotech Co., Ltd.
Report dateOct 19, 2022
Recall initiation dateAug 9, 2022
Quantity620,000 tests
LocationChangzhou, N/A, China

Official product description

Jiangsu Well Biotech Co.,Ltd. AND SDI LABS COVID-19 Ag Rapid Test Device - Cat#: CO-02

Why the product was recalled

Distribution of COVID-19 Ag Rapid Test kits in the U.S. without an Emergency Use Authorization, or a Pre-Market Approval or Clearance.

Distribution information

U.S.: CA (pending firm supplying additional distribution locations/consignee list). O.U.S.: N/A

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.